activation level, ii) to profile type 2 diabetes (T2D) patients by activation level in both countries, and iii) to assess health outcomes of patients by activation level in both countries.… Click to show full abstract
activation level, ii) to profile type 2 diabetes (T2D) patients by activation level in both countries, and iii) to assess health outcomes of patients by activation level in both countries. OBJECTIVE CATALYSTS DRIVING SUCCESSFUL DECISIONS IN LIFE SCIENCES AssEssmEnT Of OuTCOmEs In AdulTs In JApAn And urBAn ChInA By pATIEnT ACTIVATIOn lEVEl Annunziata K1; Fukuda T2; Sternbach N1; Stankus AP1; Doane MJ1; Carpinella CM1; Zhao X3; Tan D4; Grillo V3; Patel PA1 1 Kantar Health, New York, USA; 2 National Institute of Public Health, Wako, Japan; 3 Kantar Health, Singapore; 4 Kantar Health, Shanghai, China PDB44
               
Click one of the above tabs to view related content.